Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Barrera

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Antiviral Research|September 14, 2025
Verteporfin is a broad-spectrum inhibitor of arboviruses and influences viral and host-based eventsCarol A Anderson, Stephanie V Trefry, Michael D Barrera, et al.
ACS Infectious Diseases|December 31, 2024
nsP2 Protease Inhibitor Blocks the Replication of New World Alphaviruses and Offer Protection in MiceOlawale S Adeyinka, Michael D Barrera, Damilohun S Metibemu, et al.
Advances in Experimental Medicine and Biology|August 31, 2019
Assessing the Anxiolytic Properties of Taurine-Derived Compounds in Rats Following Developmental Lead Exposure: A Neurodevelopmental and Behavioral Pharmacological Pilot StudyLorenz S Neuwirth, Bright U Emenike, Eddy D Barrera, et al.
Scientific Reports|April 6, 2023
Disruptive lysosomal-metabolic signaling and neurodevelopmental deficits that precede Purkinje cell loss in a mouse model of Niemann-Pick Type-C diseaseSarah Kim, Kathleen Ochoa, Sierra E Melli, et al.
Advances in Experimental Medicine and Biology|July 26, 2022
Taurine-Derived Compounds Produce Anxiolytic Effects in Rats Following Developmental Lead ExposureLorenz S Neuwirth, Bright U Emenike, George B Cruz, et al.
JCI Insight|May 8, 2023
ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination aloneMargaret C Costanzo, Dominic Paquin-Proulx, Alexandra Schuetz, et al.
Science Translational Medicine|April 2, 2025
Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filovirusesThembi Mdluli, Suzanne Wollen-Roberts, Mélanie Merbah, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Antiviral Research|September 14, 2025
Verteporfin is a broad-spectrum inhibitor of arboviruses and influences viral and host-based eventsCarol A Anderson, Stephanie V Trefry, Michael D Barrera, et al.
ACS Infectious Diseases|December 31, 2024
nsP2 Protease Inhibitor Blocks the Replication of New World Alphaviruses and Offer Protection in MiceOlawale S Adeyinka, Michael D Barrera, Damilohun S Metibemu, et al.
Advances in Experimental Medicine and Biology|August 31, 2019
Assessing the Anxiolytic Properties of Taurine-Derived Compounds in Rats Following Developmental Lead Exposure: A Neurodevelopmental and Behavioral Pharmacological Pilot StudyLorenz S Neuwirth, Bright U Emenike, Eddy D Barrera, et al.
Scientific Reports|April 6, 2023
Disruptive lysosomal-metabolic signaling and neurodevelopmental deficits that precede Purkinje cell loss in a mouse model of Niemann-Pick Type-C diseaseSarah Kim, Kathleen Ochoa, Sierra E Melli, et al.
Advances in Experimental Medicine and Biology|July 26, 2022
Taurine-Derived Compounds Produce Anxiolytic Effects in Rats Following Developmental Lead ExposureLorenz S Neuwirth, Bright U Emenike, George B Cruz, et al.
JCI Insight|May 8, 2023
ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination aloneMargaret C Costanzo, Dominic Paquin-Proulx, Alexandra Schuetz, et al.
Science Translational Medicine|April 2, 2025
Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filovirusesThembi Mdluli, Suzanne Wollen-Roberts, Mélanie Merbah, et al.
Pageof 7